NotebookLM vs Causaly (2026)

NotebookLM

by Google

Causaly

by Causaly

Pros

• ✓Source-grounded RAG architecture refuses to extrapolate beyond uploaded material, dramatically reducing hallucination compared to general-purpose LLMs on document-specific queries
• ✓Audio Overviews convert dense documents into engaging two-host podcast conversations -- a viral feature with no real competitor
• ✓Generous free tier (100 notebooks, 50 sources each) covers most individual research needs without payment

Limitations

• ⚠No API exists -- programmatic or bulk workflows require Gemini API directly, not NotebookLM
• ⚠Refuses to bridge uploaded sources with external knowledge -- queries like "is this consistent with recent research" fail unless the recent research is uploaded
• ⚠Audio Overview format is locked to two-host podcast style with no control over voices, depth, or topic emphasis

Pros

• ✓Biomedical knowledge graph is genuinely differentiated — Causaly's proprietary graph captures gene/protein/disease/drug relationships that horizontal AI research tools cannot match, materially better evidence-based R&D outcomes than tools relying purely on text-based literature search
• ✓Agentic AI for specific R&D use cases — AI agents purpose-built for target identification, drug repositioning, mechanism investigation, and safety assessment provide materially better outcomes than general-purpose research agents that lack pharmaceutical R&D specialization
• ✓Strong life sciences enterprise reference base — substantial pharmaceutical and biotech customer adoption with Pulitzer-winning thought leadership content provides procurement validation that de-risks enterprise R&D investments

Limitations

• ⚠Enterprise-only pricing inaccessible to academic researchers and startups — Causaly deployments at $200K+/year exclude individual researchers, small biotech startups, and academic research teams that need lighter-weight life sciences AI tools
• ⚠Specialized for life sciences limits cross-domain value — Causaly is purpose-built for biomedical R&D and provides no value for non-life-sciences research domains, hard constraint for organizations with diverse research needs
• ⚠Implementation complexity from R&D-specific configuration — biomedical knowledge graph setup, AI agent configuration for R&D workflows, and integration with proprietary pharmaceutical databases require sustained life sciences expertise beyond just technology deployment